Louisville, Ky — Michael Marvin, director of liver transplantation at the University of Louisville and at Jewish Hospital, has been named chief of the division of transplant surgery at UofL. The appointment was announced by Kelly McMasters, chair of the UofL department of surgery, on Thursday, Jan. 14.
Under Marvin’s guidance, the liver transplant program set a state record in 2009 with 54 liver transplants performed. No program in the state has ever performed as many liver transplants.
“Michael has demonstrated exceptional leadership qualities in his roles as director of liver transplantation here at UofL and at Jewish Hospital, and he is a natural choice to lead the transplant division as a whole,” McMasters said. “I am looking forward to continuing to work with Michael as we strive to touch more patients from Kentucky, Indiana and other areas who are in need of liver, kidney and pancreas transplants.”
Marvin said there are already plans in place for greater regional outreach.
“Establishing outreach clinics outside of Louisville to address the needs of patients in surrounding areas is a major goal of mine,” he said. “I’m thrilled to have the opportunity to lead this division in some new endeavors while continuing to work with my colleagues at UofL and at Jewish as we build on the work we’ve been doing and hopefully celebrate more achievements down the road.”
Prior to coming to Louisville, Marvin was on the faculty of New York Medical College and was a liver transplant and hepatobiliary – or liver, gallbladder and bile duct – surgeon at Westchester Medical Center in New York. He completed all of his surgical training at the New York Presbyterian Hospital of Columbia University in New York City. He graduated from the Columbia University College of Physicians & Surgeons in New York in 1992, where he was elected to the Alpha Omega Alpha medical honor society.
Marvin’s main clinical focus is liver transplantation, hepatobiliary surgery and minimally invasive hepatobiliary surgery, as well as management of primary liver cancer. He has research interests in organ donation, liver transplantation outcomes, and the relationship between control of blood sugars and outcomes in critically ill patients.